The company notes that ProstACT Global study is an international, multi-centre trial in two parts. Part 1 is a safety and ...
As previously agreed with FDA and disclosed to the market, Telix will submit Part 1 data to the United States (U.S.) Food and Drug Administration (FDA) to enable clearance to expand Part 2 of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback